Discuss This Drug

guselkumab

CHEBI:CHEBI_753137

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
Guselkumab
rxcui
2693097
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
dosage_form
INJECTION
active_ingredient_strength
200 mg/2mL
route
INTRAVENOUS
marketing_category
BLA
marketing_start_date
20170713
package_marketing_start_date
20170713
nui
N0000192798
pharm_class_epc
Interleukin-23 Antagonist [EPC]
pharm_class
Interleukin-23 Antagonists [MoA]
pharm_class_moa
Interleukin-23 Antagonists [MoA]
labeler_name
Janssen Biotech, Inc.
manufacturer_name
Janssen Biotech, Inc.
brand_name
TREMFYA
brand_name_base
TREMFYA
product_ndc
57894-650
application_number
BLA761061
spl_id
22ccf009-6795-1f75-e063-6394a90ae70a
active_ingredient_name
GUSELKUMAB
package_ndc
57894-650-02
package_description
1 VIAL, SINGLE-DOSE in 1 CARTON (57894-650-02) / 20 mL in 1 VIAL, SINGLE-DOSE (57894-650-01)
unii
089658A12D
spl_set_id
1e6dc9ae-1c4c-42d9-87aa-c315ecc51b56
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class